Table 3.
Comparison of the changes in serum 25-hydroxyvitamin D levels between the experimental and control groups.
| 25-hydroxyvitamin D (ng/ml) | Experimental group (n = 64) | Control group (n = 72) | p valuea | p valueb |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||
| Baseline | 21.15 ± 10.19 | 22.04 ± 10.42 | 0.618 | |
| Week 2 | 21.40 ± 9.85 | 20.97 ± 10.13 | ||
| Δ | 0.25 ± 3.10 | −1.07 ± 2.68 | 0.009 | 0.018 |
| p valuec | 0.523 | 0.001 | ||
| Week 4 | 21.90 ± 9.58 | 20.28 ± 10.07 | ||
| Δ | 0.75 ± 3.98 | −1.75 ± 3.04 | <0.001 | <0.001 |
| p-valuec | 0.139 | <0.001 | ||
| Week 6 | 22.14 ± 9.53 | 20.33 ± 9.69 | ||
| Δ | 0.99 ± 4.97 | −1.70 ± 3.64 | 0.001 | 0.002 |
| p valuec | 0.117 | <0.001 |
Data are presented as mean ± standard deviation.
Δ represents a change from baseline.
SD standard deviation.
aIndependent t-test was performed to examine between-group differences.
bAnalysis of covariance adjusted for age, sex, time spent on outdoor activities, dietary vitamin D intake, compliance with device use, season of study enrollment, and baseline serum 25-hydroxyvitamin D levels, was performed to examine between-group differences.
cPaired t-test was performed to examine within-group differences in changes from baseline serum vitamin D levels.